In Progress |
2021 - Present |
Investigation of the Molecular Inhibition Mechanism and Binding Energies Between Pro-Inflammatory Enzymes and Iridoid Compounds Isolated from Kelulut for Allergy-Related Symptoms |
2021 - Present |
Depression, Anxiety and Stress Levels Among Frontliners of SASMEC@IIUM and IIUM Kuantan During Covid-19 Pandemic : Its Associated Factors and Impact of Brief Psycoeducation Group Intervention |
2021 - Present |
Depression, Anxiety and Stress Levels Among Frontliners of SASMEC@IIUM and IIUM Kuantan During Covid-19 Pandemic : Its Associated Factors and Impact of Brief Psycoeducation Group Intervention |
2021 - Present |
The Development of the Medical Assistance Robot, MediBOT |
2021 - Present |
The Development of the Medical Assistance Robot, MediBOT |
2020 - Present |
A Phase 3 Randomized, Open-label (Sponsor-Blind), Active-controlled, Parallel-group, Multi-center, Event Driven in Non-Dialysis Subjects with Anemia Associated with Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin (ASCEND) |
2020 - Present |
A Phase 3 Randomized, Open-label (Sponsor-Blind), Active-controlled, Parallel-group, Multi-center, Event Driven in Non-Dialysis Subjects with Anemia Associated with Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin (ASCEND) |
Completed |
2016 - 2017 |
An Asian, Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-week Study of DS-5565 in Patients with Diabetic Peripheral Neuropathic Pain Followed by A 52-week Open-Label Extension |
2016 - 2018 |
A cross-sectional study on the quality of life for patients with diabetic neuropathy pain
|
2016 - 2020 |
Development and Formulation of a fixed dose combination of carbamazepine and gabapentin a Novel Approach to Increase Therapeutic efficacy for Peripheral Neuropathic Pain in Diabetic Patient |
2016 - 2017 |
An Asian, Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-week Study of DS-5565 in Patients with Diabetic Peripheral Neuropathic Pain Followed by A 52-week Open-Label Extension |
2016 - 2020 |
Development and Formulation of a fixed dose combination of carbamazepine and gabapentin a Novel Approach to Increase Therapeutic efficacy for Peripheral Neuropathic Pain in Diabetic Patient |
2016 - 2018 |
A cross-sectional study on the quality of life for patients with diabetic neuropathy pain
|
2016 - 2019 |
Development of depression symptoms model for thyroid disorders patients in Malaysia |
2016 - 2019 |
Development of depression symptoms model for thyroid disorders patients in Malaysia |
2015 - 2019 |
A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects with Type 2 Diabetes Mellitus and Diabetic Mellitus and Diabetic Nephropathy (The CREDENCE Trial) |
2014 - 2018 |
A Randomized Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled, Study of the Effects of Atrasentan on Renal Outcomes in Type 2 Diabetic Subjects with Nephropathy |
2014 - 2018 |
Content Validity by using Confirmatory Factor Analysis of Newly Designed Family Scales; Skala Ciri Kekeluargaan Asia and Asia Family Characteristics Scale |
2014 - 2016 |
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects with Type 2 diabetes at High Risk of Cardiovascular Events and Trial Product Insulin Degludec |
2014 - 2018 |
Content Validity by using Confirmatory Factor Analysis of Newly Designed Family Scales; Skala Ciri Kekeluargaan Asia and Asia Family Characteristics Scale |
2014 - 2016 |
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects with Type 2 diabetes at High Risk of Cardiovascular Events and Trial Product Insulin Degludec |
2014 - 2018 |
A Randomized Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled, Study of the Effects of Atrasentan on Renal Outcomes in Type 2 Diabetic Subjects with Nephropathy |
2013 - 2016 |
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Access Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus (The MK-3102-018-trial) |
2013 - 2016 |
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Access Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus (The MK-3102-018-trial) |
2012 - 2016 |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus |
2012 - 2016 |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus |
2011 - 2018 |
A Multicenter, International, Randomized, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk (The CAROLINA Trial) |
2011 - 2012 |
Study of Prevalence of Psychiatric Illness among Diabetic Patients in Hospital Tengku Ampuan Afzan, Pahang, Malaysia |
2011 - 2013 |
(RU2011) Applying the 'Case Method' in the teaching of Basic Medical Science in a Medical curriculum |
2011 - 2018 |
A Multicenter, International, Randomized, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk (The CAROLINA Trial) |
2011 - 2012 |
Study of Prevalence of Psychiatric Illness among Diabetic Patients in Hospital Tengku Ampuan Afzan, Pahang, Malaysia |
2011 - 2013 |
(RU2011) Applying the 'Case Method' in the teaching of Basic Medical Science in a Medical curriculum |
2010 - 2018 |
A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk
|
2010 - 2015 |
A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10mg and 25mg administered orally once daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients with Increased Cardiovascular Risk
|
2010 - 2018 |
A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk
|
2010 - 2015 |
A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10mg and 25mg administered orally once daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients with Increased Cardiovascular Risk
|
2008 - 2013 |
New Title : A Preliminary Study of Paraoxonase Activity in the Healty Population and Coronary Aretry Disease Patients in Malaysia
Old Title: A Study of Prevalence of False Positive HCV ELISA in Malaysia - Towards Developing A New and More Effective Treatment Protocol with Available Anti-Viral Drug |
2008 - 2013 |
New Title : A Preliminary Study of Paraoxonase Activity in the Healty Population and Coronary Aretry Disease Patients in Malaysia
Old Title: A Study of Prevalence of False Positive HCV ELISA in Malaysia - Towards Developing A New and More Effective Treatment Protocol with Available Anti-Viral Drug |
2008 - 2017 |
Diabcare Asia 2008 (Malaysia): A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Compilations, Psychosocial Aspects of Diabetic Patients in Asia to Evaluate Perceptions and Practices OD Physicians & Patients About Diabetic Managements in Asia Observational Study |
2008 - 2017 |
Diabcare Asia 2008 (Malaysia): A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Compilations, Psychosocial Aspects of Diabetic Patients in Asia to Evaluate Perceptions and Practices OD Physicians & Patients About Diabetic Managements in Asia Observational Study |